| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Chen PM et al. | Remission induction of ANLL with low dose cytosine arabinoside combined with retinoic acid. | 1990 | Zhonghua Yi Xue Za Zhi (Taipei) | pmid:2178062 |
| Schwanitz HJ | [Problematic aspects of placebo-controlled double-blind studies with highly effective drugs such as etretinate]. | 1987 | Z. Hautkr. | pmid:3303711 |
| Thiele B et al. | [Generalized verrucosis in familial T-helper cell deficiency. Treatment with interferon and Tigason]. | 1985 | Z. Hautkr. | pmid:2992176 |
| Salamon T | [Contribution to the question of keratodermia palmo-plantaris insularis et striata. The phenomenon of the focal character of phenotypic expression of the pathological gene (author's transl)]. | 1981 | Z. Hautkr. | pmid:6454309 |
| Mahrle G | [Retinoids and carcinogenesis]. | 1984 | Z. Hautkr. | pmid:6528691 |
| Gabrielsen TO | [Tigason in hyperkeratosis lenticularis perstans (HLP)--a case report]. | 1986 | Z. Hautkr. | pmid:3962407 |
| Sommeregger K and Schuller-Petrović S | [Granuloma disseminatum partim anulare partim papulosum. Clinical variant of granuloma anulare disseminatum--therapeutic trial with etretinate]. | 1986 | Z. Hautkr. | pmid:3962410 |
| Uhlmann A and Bräuninger W | [Therapeutic results with the aromatic retinoid (Tigason) in Sharp syndrome and progressive scleroderma]. | 1985 | Z. Hautkr. | pmid:4013454 |
| Sönnichsen N et al. | [Psoriasis therapy with the aromatic retinoid Ro 10-9359 (Tigason)]. | 1983 | Z. Hautkr. | pmid:6636927 |
| Köster W and Nasemann T | [Hereditary papulotranslucent acrokeratoderma]. | 1985 | Z. Hautkr. | pmid:3157274 |
| Schwanitz HJ | [Informing the patient before treatment with etretinate]. | 1984 | Z. Hautkr. | pmid:6719976 |
| Magyarlaki M et al. | [A case of erythrokeratodermia figurata variabilis successfully treated with tigason]. | 1989 | Z. Hautkr. | pmid:2531508 |
| Thiele B et al. | [Preliminary results of Re-PUVA therapy in cutaneous T-cell lymphomas]. | 1985 | Z. Hautkr. | pmid:3872538 |
| Mashkilleysson AL and Mashkilleysson NA | [Treatment of congenital erythroderma ichthyosiforme in mother and son with the oral aromatic retinoid Ro 10-9359. The need for maintenance therapy]. | 1983 | Z. Hautkr. | pmid:6415945 |
| Mensing H and Wagner G | [Etretinate therapy in solitary keratoacanthomas]. | 1988 | Z. Hautkr. | pmid:3388928 |
| Salamon T et al. | [Meleda disease - akroerythrokeratoderma]. | 1982 | Z. Hautkr. | pmid:6211845 |
| Haustein UF and Heilmann S | [Bone changes in long-term therapy with etretinate (Tigason)]. | 1987 | Z. Hautkr. | pmid:3590912 |
| Chou RC et al. | A potentially new metabolic pathway: ethyl esterification of acitretin. | 1992 | Xenobiotica | pmid:1413887 |
| Ruzicka T et al. | [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy]. | 1987 | Wien. Klin. Wochenschr. | pmid:3324494 |
| Shin SY et al. | Blood donors on teratogenic drugs and donor deferral periods in a clinical situation. | 2012 | Vox Sang. | pmid:22211799 |
| Samsonov VA and Gareginian SA | [Tigazon in the therapy of patients with circumscribed scleroderma]. | 1990 | Vestn Dermatol Venerol | pmid:2288145 |
| Kalamkarian AA et al. | [Tigason in the treatment of psoriasis and various dermatoses]. | 1985 | Vestn Dermatol Venerol | pmid:4050091 |
| MashkilleÄson AL and MashkilleÄson NA | [Ichthyosiform erythroderma successfully treated with an aromatic retinoid]. | 1984 | Vestn Dermatol Venerol | pmid:6382860 |
| ShakhtmeÄster IIa et al. | [Experience with the treatment of psoriatic arthritis using tigazon]. | 1986 | Vestn Dermatol Venerol | pmid:3705734 |
| MashkilleÄson AL et al. | [Treatment of lichen ruber planus of the oral mucosa using an aromatic retinoid (RO 10-9359)]. | 1986 | Vestn Dermatol Venerol | pmid:3705735 |
| Skripkin IuK et al. | [The therapeutic efficacy of tigazon in treating dermatoses]. | 1990 | Vestn Dermatol Venerol | pmid:2402940 |
| Kalamkarian AA et al. | [Clinico-morphological variants and problems of therapy of Darier's keratosis follicularis]. | 1988 | Vestn Dermatol Venerol | pmid:3414166 |
| Abal'iants LA and Talanin NIu | [Lewandowsky-Lutz epidermodysplasia verruciformis associated with vitiligo]. | 1988 | Vestn Dermatol Venerol | pmid:3414173 |
| Fujita J et al. | Therapeutic effect of a retinoid (Ro 10-9359) on rats with bladder tumours induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine upon administration alone or in combination with mitomycin C. | 1983 | Urol. Res. | pmid:6419428 |
| Halkier-Sørensen L and Andresen JH | [Etretinate (Tigason) and bone changes]. | 1988 | Ugeskr. Laeg. | pmid:3291352 |
| Jellouli A et al. | [Epidermal verrucous linear inflammatory hamartoma (3 cases)]. | 1993 | Tunis Med | pmid:8134963 |
| Oguchi H | [Application of the aromatic retinoid etretinate in oral cancer therapy. Experimental study of the use of the aromatic retinoid etretinate alone and in combination with peplomycin in oral cancer therapy]. | 1984 | Tsurumi Shigaku | pmid:6204429 |
| Satoh J | [Electron microscopy studies of tissue changes in the epithelium of hamster cheek pouch caused by the application of the aromatic retinoid etretinate and peplomycin, separately and in combination]. | 1986 | Tsurumi Shigaku | pmid:2425467 |
| Kelly GE | Effect of retinoid therapy on rat cardiac allograft survival. | 1987 | Transplantation | pmid:3307065 |
| Rook AH et al. | Beneficial effect of low-dose systemic retinoid in combination with topical tretinoin for the treatment and prophylaxis of premalignant and malignant skin lesions in renal transplant recipients. | 1995 | Transplantation | pmid:7886798 |
| Stosić-Grujicić S et al. | Etretinate (Ro 10-9359) prevents autoimmune syndrome associated with chronic graft-versus-host disease in rats. | 1996 | Transplant. Proc. | pmid:8962263 |
| Park HD et al. | Evaluation of the transfusion safety of blood products and determination of plasma concentrations of acitretin and etretinate in patients receiving transfusions. | 2008 | Transfusion | pmid:18657077 |
| Desablens B et al. | [Manifestations of Hodgkin's disease caused by retinoids?]. | 1989 Jul-Aug | Therapie | pmid:2595650 |
| Schuppli R | [Treatment of psoriasis with etretinate (Tigason)]. | 1986 | Ther Umsch | pmid:3535152 |
| Verret JL | [Etretinate and the prevention of skin cancers]. | 1986 | Ther Umsch | pmid:3535154 |
| Klein J et al. | Therapeutic drug monitoring of retinoids. | 1992 | Ther Drug Monit | pmid:1412605 |
| Rosa FW et al. | Teratogen update: vitamin A congeners. | 1986 | Teratology | pmid:3461576 |
| Agnish ND et al. | Teratogenicity of etretinate during early pregnancy in the rat and its correlation with maternal plasma concentrations of the drug. | 1990 | Teratology | pmid:2144063 |
| Harnish DC et al. | Mouse conceptuses have a limited capacity to elevate the mRNA level of cellular retinoid binding proteins in response to teratogenic doses of retinoic acid. | 1992 | Teratology | pmid:1332208 |
| Jacobsson C | Teratological studies on craniofacial malformations. | 1997 | Swed Dent J Suppl | pmid:9200351 |
| Dréno B | Roferon-A (interferon alpha 2a) combined with Tigason (etretinate) for treatment of cutaneous T cell lymphomas. | 1993 | Stem Cells | pmid:8401250 |
| Kalamkarian AA et al. | [New methods of treating dermatoses with disordered keratinization processes]. | 1987 | Sov Med | pmid:2447657 |
| Holland DB et al. | Epidermal keratin levels during oral 1-alpha-hydroxyvitamin D3 treatment for psoriasis. | 1989 | Skin Pharmacol. | pmid:2483330 |
| Monga M | Vitamin A and its congeners. | 1997 | Semin. Perinatol. | pmid:9201819 |
| Gutierrez-Mazariegos J et al. | Vitamin A: a multifunctional tool for development. | 2011 | Semin. Cell Dev. Biol. | pmid:21693195 |
Etretinate
Etretinate is a lipid of Prenol Lipids (PR) class. Etretinate is associated with abnormalities such as Psoriasis, Skin lesion, Scleroderma, Chronic graft-versus-host disease and Evaluable Disease. The involved functions are known as Agent, Ulcer and Teratogenesis. Etretinate often locates in Hepatic and Skin. The related lipids are Steroids and Steroid, Systemic.
Cross Reference
Introduction
To understand associated biological information of Etretinate, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Etretinate?
Etretinate is suspected in Scleroderma, Chronic graft-versus-host disease, Psoriasis, Skin lesion, Evaluable Disease, Pneumonia, Bacterial and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with Etretinate
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Etretinate?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Etretinate?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Etretinate?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Etretinate?
There are no associated biomedical information in the current reference collection.
What common seen animal models are associated with Etretinate?
There are no associated biomedical information in the current reference collection.